JHU 37152

Pricing Availability   Qty
说明: High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant
化学名: 8-Chloro-11-(4-ethylpiperazin-1-yl)-1-fluoro-5H-dibenzo[b,e][1,4]diazepine
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (3)

生物活性 for JHU 37152

JHU 37152 is a high affinity and highly potent activator of hM3Dq and hM4Di DREADDs (Ki values are 1.8 nM and 8.7 nM for hM3Dq and hM4Di in vitro, respectively; EC50 values are 5 nM and 0.5 nM for hM3Dq and hM4Di in vitro, respectively). Selectively displaces [3H]clozapine from DREADDs in vivo, but not from other clozapine binding sites. Inhibits locomotor activity in mice expressing hM3Dq and hM4Di in D1-expressing neurons. Brain penetrant in mice, rats and non-human primates.

技术数据 for JHU 37152

分子量 358.85
公式 C19H20ClFN4
储存 Store at RT
纯度 ≥98% (HPLC)
CAS Number 2369979-67-7
PubChem ID 139033721
InChI Key NZMZJNNWMSYDNX-UHFFFAOYSA-N
Smiles CCN1CCN(C2=NC3=CC(Cl)=CC=C3NC4=CC=CC(F)=C24)CC1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for JHU 37152

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 35.88 100
ethanol 35.88 100

制备储备液 for JHU 37152

以下数据基于产品分子量 358.85。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.79 mL 13.93 mL 27.87 mL
5 mM 0.56 mL 2.79 mL 5.57 mL
10 mM 0.28 mL 1.39 mL 2.79 mL
50 mM 0.06 mL 0.28 mL 0.56 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for JHU 37152

参考文献是支持产品生物活性的出版物。

Bonaventura et al (2019) High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nat.Commun. 10 4627 PMID: 31604917


If you know of a relevant reference for JHU 37152, please let us know.

按标靶查看相关产品

关键词: JHU 37152, JHU 37152 supplier, JHU37152, DREADD, agonist, agonists, activator, activators, actuator, muscarinic, hM3Dq, hM4Di, brain, penetrant, DREADDs, 7197, Tocris Bioscience

篇 JHU 37152 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 JHU 37152 的引用文献。 您是否知道使用了 Tocris JHU 37152 的优秀论文? 请告知我们.

JHU 37152 的评论

目前没有该产品的评论。 Be the first to review JHU 37152 and earn rewards!

Have you used JHU 37152?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Chemogenetics Research Bulletin

Chemogenetics Research Bulletin

Produced by Tocris, the chemogenetics research bulletin provides an introduction to chemogenetic methods to manipulate neuronal activity. It outlines the development of RASSLs, DREADDs and PSAMs, and the use of chemogenetic compounds. DREADD ligands and PSEMs available from Tocris are highlighted.

Allosteric GPCR Pharmacology Poster

Allosteric GPCR Pharmacology Poster

G protein-coupled receptors (GPCRs) are intrinsically allosteric proteins. This poster provides insights into allosteric mechanisms of GPCR biology, highlighting key facets of GPCR allostery and therapeutic applications of allosteric modulators.

GPCR Efficacy and Biased Agonism Poster

GPCR Efficacy and Biased Agonism Poster

GPCRs can interact with multiple distinct transducers or regulatory proteins and these can be preferentially engaged in an agonist-specific manner giving rise to biased agonism. This poster discusses cutting edge GPCR signaling pharmacology and highlights therapeutic applications of biased agonism.